Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunogenicity of Fractional Dose of the HPV Vaccines

NCT05291871 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.

NCT NCT05291871
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05291871 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunogenicity of Fractional Dose of the HPV Vaccines
Lead sponsor
University of Washington
Phase
Phase 4
Overall status
Active, not recruiting
Start date
June 15, 2022
Completion date
December 31, 2026
Enrollment
92 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hpv infection, hpv vaccine